XML 52 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings Per Share
9 Months Ended
Sep. 30, 2017
Earnings Per Share  
Earnings Per Share

24. Earnings Per Share

The following tables provide the calculation of earnings per share and the reconciliation of earnings per share and earnings per diluted share:
20172016(a)
For the three months ended September 30, AveragePer ShareAveragePer Share
(in millions, except per share data)IncomeSharesAmountIncomeSharesAmount
Earnings Per Share:
Net income available to common shareholders$999501
Less: Income allocated to participating securities105
Net income allocated to common shareholders$9897211.374967510.66
Earnings Per Diluted Share:
Net income available to common shareholders$999501
Effect of dilutive securities:
Stock-based awards-12-7
Net income available to common shareholders plus assumed conversions999501
Less: Income allocated to participating securities105
Net income allocated to common shareholders
plus assumed conversions$9897331.354967580.65

Average common shares outstanding - diluted were adjusted for the three months ended September 30, 2016 related to the early adoption of ASU 2016-09 during the fourth quarter of 2016, with an effective date of January 1, 2016

20172016(a)
For the nine months ended September 30,AveragePer ShareAveragePer Share
(in millions, except per share data)IncomeSharesAmountIncomeSharesAmount
Earnings Per Share:
Net income available to common shareholders$1,6331,118
Less: Income allocated to participating securities1812
Net income allocated to common shareholders$1,6157372.191,1067611.45
Earnings Per Diluted Share:
Net income available to common shareholders$1,6331,118
Effect of dilutive securities:
Stock-based awards-12-6
Net income available to common shareholders plus assumed conversions1,6331,118
Less: Income allocated to participating securities1812
Net income allocated to common shareholders
plus assumed conversions$1,6157492.161,1067671.44

Net tax deficiencies of $6 were reclassified from capital surplus to applicable income tax expense and average common shares outstanding - diluted were adjusted for the nine months ended September 30, 2016 related to the early adoption of ASU 2016-09 during the fourth quarter of 2016, with an effective date of January 1, 2016

Shares are excluded from the computation of earnings per diluted share when their inclusion has an anti-dilutive effect on earnings per share. The diluted earnings per share computation for the three and nine months ended September 30, 2017 excludes 4 million and 5 million, respectively, of SARs and an immaterial amount of stock options because their inclusion would have been anti-dilutive. The diluted earnings per share computation for the three and nine months ended September 30, 2016 excludes 20 million and 23 million, respectively, of SARs and an immaterial amount of stock options because their inclusion would have been anti-dilutive.

The diluted earnings per share computation for the three and nine months ended September 30, 2017 excludes the impact of the forward contract related to the August 17, 2017 accelerated share repurchase transaction. Based upon the average daily volume weighted-average price of the Bancorp’s common stock during the third quarter of 2017, the counterparty to the transaction would have been required to deliver additional shares for the settlement of the forward contract as of September 30, 2017, and thus the impact of the forward contract related to the accelerated share repurchase transaction would have been anti-dilutive to earnings per share.

The diluted earnings per share computation for the three and nine months ended September 30, 2016 excludes the impact of the forward contract related to the August 5, 2016 accelerated share repurchase transaction. Based upon the average daily volume weighted-average price of the Bancorp’s common stock during the third quarter of 2016, the counterparty to the transaction would have been required to deliver additional shares for the settlement of the forward contract as of September 30, 2016, and thus the impact of the forward contract related to the accelerated share repurchase transaction would have been anti-dilutive to earnings per share.